BPC-157 is a research compound and has not been approved by Health Canada for human consumption or therapeutic use
36 studies reviewed (1993-2024) Mechanism: NO system modulation, VEGF/angiogenesis, FAK-paxillin migration pathway Clinical Status: Not FDA or EMA approved
Vitamin D injections : Therapeutic doses vary but often include amounts like 50,000 IU for treating deficiencies
Possible mild effects : local injection site soreness, slight flushing Rare : nausea, dizziness, allergic reaction Contraindications : hypersensitivity to any component
Yes it works with any lyophilised peptide
If your goal is to reduce abdominal fat, the path still runs through a sustainable calorie deficit, consistent training, adequate sleep, and proper nutrition